Catherine Ann (Saenz) Bonham MD
Critical Care Medicine, Interstitial Lung Diseases, Occupational & Environmental Lung Disease
Associate Professor, Scientific Director of Interstitial Lung Disease and Sarcoidosis Program
Join to View Full Profile
1221 PO BoxFl 2Charlottesville, VA 22908
Phone+1 434-924-5219
Fax+1 434-924-9720
Dr. Bonham is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Catherine Bonham is a pulmonologist in Charlottesville, VA and is affiliated with multiple hospitals in the area, including University of Virginia Medical Center and University of Virginia Medical Center. She received her medical degree from University of Michigan Medical School and has been in practice 10 years. She specializes in critical care medicine, interstitial lung diseases, and occupational & environmental lung disease and is experienced in diagnosis and treatment of interstitial lung diseases (ild) including idiopathic pulmonary fibrosis (ipf) and sarcoidosis.
Education & Training
University of ChicagoFellowship, Pulmonary Disease and Critical Care Medicine, 2012 - 2016
University of MichiganResidency, Internal Medicine/Pediatrics, 2007 - 2011
University of Michigan Medical SchoolClass of 2007
Harvard UniversityAB, Cum Laude, 1996 - 2000
Certifications & Licensure
VA State Medical License 2018 - 2026
IL State Medical License 2012 - 2020
MI State Medical License 2007 - 2015
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- A Study to Assess the Efficacy and Safety of Namilumab in Participants With Chronic Pulmonary Sarcoidosis Start of enrollment: 2022 Aug 31
- A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis Start of enrollment: 2023 Nov 10
Publications & Presentations
PubMed
- The Impact of the Unknown: Patient Experiences With Uncertainty in Sarcoidosis.Kristen R Mathias, Michelle N Eakin, Katrina E Hauschildt, Edward S Chen, Nisha A Gilotra
Chest. 2025-12-01 - 2 citationsA paradigm shift in corticosteroid therapy for sarcoidosis: a World Association of Sarcoidosis and Other Granulomatous Disorders Position Paper, endorsed by the Americ...Athol U Wells, Elyse E Lower, Robert P Baughman, Daniel A Culver, Marc A Judson
The Lancet. Respiratory Medicine. 2025-11-06 - Active Antigen-Specific Adaptive Immune Responses Are Shared among Patients with Progressive Fibrotic Interstitial Lung Disease.Tania E Velez, Young Me Yoon, Vaibhav Upadhyay, Sara E Vazquez, Cathryn T Lee
American Journal of Respiratory and Critical Care Medicine. 2025-10-01
Press Mentions
Learning in the Midst of the COVID-19 Pandemic: Researchers, Clinicians Weigh InAugust 14th, 2020- Q&A: From the Front Lines, Dr. Catherine Bonham Talks COVID-19July 14th, 2020
Two Biomarkers Appear to Predict Course of IPFMay 15th, 2017
Grant Support
- T cells in IPFNIH2019–2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
